These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 23678583)

  • 21. Prevalence of negative symptoms in outpatients with schizophrenia spectrum disorders treated with antipsychotics in routine clinical practice: findings from the CLAMORS study.
    Bobes J; Arango C; Garcia-Garcia M; Rejas J;
    J Clin Psychiatry; 2010 Mar; 71(3):280-6. PubMed ID: 19895779
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effectiveness and cost of atypical versus typical antipsychotic treatment for schizophrenia in routine care.
    Stargardt T; Weinbrenner S; Busse R; Juckel G; Gericke CA
    J Ment Health Policy Econ; 2008 Jun; 11(2):89-97. PubMed ID: 18509216
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risk of treatment-emergent diabetes mellitus in patients receiving antipsychotics.
    Citrome LL; Holt RI; Zachry WM; Clewell JD; Orth PA; Karagianis JL; Hoffmann VP
    Ann Pharmacother; 2007 Oct; 41(10):1593-603. PubMed ID: 17785613
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Survey on schizophrenia treatment in Mexico: perception and antipsychotic prescription patterns.
    Apiquian R; Fresán A; de la Fuente-Sandoval C; Ulloa RE; Nicolini H
    BMC Psychiatry; 2004 Apr; 4():12. PubMed ID: 15109398
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Urban birth and risk of schizophrenia: a worrying example of epidemiology where the data are stronger than the hypotheses.
    McGrath J; Scott J
    Epidemiol Psichiatr Soc; 2006; 15(4):243-6. PubMed ID: 17203614
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Improving patient outcomes in schizophrenia: achieving remission.
    Nasrallah HA; Lasser R
    J Psychopharmacol; 2006 Nov; 20(6 Suppl):57-61. PubMed ID: 17046987
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comorbidity of schizophrenia and cancer: clinical recommendations for treatment.
    Damjanović A; Ivković M; Jasović-Gasić M; Paunović V
    Psychiatr Danub; 2006 Jun; 18(1-2):55-60. PubMed ID: 16804500
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Schizophrenia and obesity: impact of antipsychotic medications.
    Wirshing DA
    J Clin Psychiatry; 2004; 65 Suppl 18():13-26. PubMed ID: 15600381
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Epidemiological study of schizophrenia on the Island of Tsushima in Nagasaki Prefecture].
    Hamada Y; Ohta Y; Nakane Y
    Seishin Shinkeigaku Zasshi; 2006; 108(2):117-31. PubMed ID: 16562513
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diabetes and schizophrenia 2005: are we any closer to understanding the link?
    Holt RI; Bushe C; Citrome L
    J Psychopharmacol; 2005 Nov; 19(6 Suppl):56-65. PubMed ID: 16280338
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Medical risk in patients with bipolar disorder and schizophrenia.
    Newcomer JW
    J Clin Psychiatry; 2006; 67 Suppl 9():25-30; discussion 36-42. PubMed ID: 16965186
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Are patients with schizophrenia under-treated with second-generation antipsychotics? A pilot study of the prescription practices of German psychiatrists.
    Hamann J; Pfeiffer H; Leucht S; Kissling W
    Pharmacopsychiatry; 2003 Nov; 36(6):309-12. PubMed ID: 14663656
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nonadherence to antipsychotic treatment in patients with schizophrenic disorders.
    Svestka J; Bitter I
    Neuro Endocrinol Lett; 2007 Feb; 28 Suppl 1():95-116. PubMed ID: 17262005
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The intercontinental schizophrenia outpatient health outcomes study (IC-SOHO): initial 6 month findings of the sample in Latin America].
    Brunner E; Gargoloff P; Caro O; González C; Landa E; González CH; Barahona A; Soria D; Tamayo J; Rovner J; Adrianzen C; Silva H; Hodge A; O'Halloran R; Assunção SS;
    Actas Esp Psiquiatr; 2006; 34(1):16-27. PubMed ID: 16525901
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quality of life in persons with schizophrenia in out-patient treatment with first- or second-generation antipsychotics.
    Kilian R; Dietrich S; Toumi M; Angermeyer MC
    Acta Psychiatr Scand; 2004 Aug; 110(2):108-18. PubMed ID: 15233711
    [TBL] [Abstract][Full Text] [Related]  

  • 36. New directions in the epidemiology of schizophrenia.
    McGrath JJ; Susser ES
    Med J Aust; 2009 Feb; 190(S4):S7-9. PubMed ID: 19220176
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epidemiology of schizophrenia: review of findings and myths.
    Messias EL; Chen CY; Eaton WW
    Psychiatr Clin North Am; 2007 Sep; 30(3):323-38. PubMed ID: 17720026
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The new epidemiology of schizophrenia.
    Jones P; Cannon M
    Psychiatr Clin North Am; 1998 Mar; 21(1):1-25. PubMed ID: 9551488
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epidemiology of schizophrenia: the global burden of disease and disability.
    Jablensky A
    Eur Arch Psychiatry Clin Neurosci; 2000; 250(6):274-85. PubMed ID: 11153962
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epidemiological studies of schizophrenia in Japan.
    Nakane Y; Ohta Y; Radford MH
    Schizophr Bull; 1992; 18(1):75-84. PubMed ID: 1553505
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.